Jurjan Aman

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 18

Top Topics

Coronavirus Disease

Pulmonary Arterial Hypertension

Top Venues

Critical care (London, England)

Circulation research

Nature communications

Arteriosclerosis, thrombosis, and vascular biology

This page only lists publications with an associated author ORCID identifier.

Publications

Erik Duijvelaar, Xiaoke Pan, Harm Jan Bogaard, Etto C Eringa, Jurjan Aman
Imatinib treatment improves hyperglycaemic dysregulation in severe COVID-19: a secondary analysis of blood biomarkers in a randomised controlled trial. Critical care (London, England) 28 (1) (2024)
Erik Duijvelaar, Jack S Gisby, James E Peters, Harm Jan Bogaard, Jurjan Aman
Longitudinal plasma proteomics reveals biomarkers of alveolar-capillary barrier disruption in critically ill COVID-19 patients. Nature communications 15 (1) (2024)
Erik Duijvelaar, Jack S Gisby, James E Peters, Harm Jan Bogaard, Jurjan Aman
Longitudinal plasma proteomics reveals biomarkers of alveolar-capillary barrier disruption in critically ill COVID-19 patients. Nature communications 15 (1) (2024)
Erik Duijvelaar, Xiaoke Pan, Harm Jan Bogaard, Etto C Eringa, Jurjan Aman
Imatinib treatment improves hyperglycaemic dysregulation in severe COVID-19: a secondary analysis of blood biomarkers in a randomised controlled trial. Critical care (London, England) 28 (1) (2024)
Erik Duijvelaar, Xiaoke Pan, Harm Jan Bogaard, Etto C Eringa, Jurjan Aman
Imatinib treatment improves hyperglycaemic dysregulation in severe COVID-19: a secondary analysis of blood biomarkers in a randomised controlled trial. Critical care (London, England) 28 (1) (2024)
Erik Duijvelaar, Xiaoke Pan, Harm Jan Bogaard, Etto C Eringa, Jurjan Aman
Imatinib treatment improves hyperglycaemic dysregulation in severe COVID-19: a secondary analysis of blood biomarkers in a randomised controlled trial. Critical care (London, England) 28 (1) (2024)
Erik Duijvelaar, Xiaoke Pan, Harm Jan Bogaard, Etto C Eringa, Jurjan Aman
Imatinib treatment improves hyperglycaemic dysregulation in severe COVID-19: a secondary analysis of blood biomarkers in a randomised controlled trial. Critical care (London, England) 28 (1) (2024)
Erik Duijvelaar, Jack S Gisby, James E Peters, Harm Jan Bogaard, Jurjan Aman
Longitudinal plasma proteomics reveals biomarkers of alveolar-capillary barrier disruption in critically ill COVID-19 patients. Nature communications 15 (1) (2024)
Erik Duijvelaar, Xiaoke Pan, Harm Jan Bogaard, Etto C Eringa, Jurjan Aman
Imatinib treatment improves hyperglycaemic dysregulation in severe COVID-19: a secondary analysis of blood biomarkers in a randomised controlled trial. Critical care (London, England) 28 (1) (2024)
Jurjan Aman, Coert Margadant
Integrin-Dependent Cell-Matrix Adhesion in Endothelial Health and Disease. Circulation research 132 (3) (2023)
Jurjan Aman, Coert Margadant
Integrin-Dependent Cell-Matrix Adhesion in Endothelial Health and Disease. Circulation research 132 (3) (2023)
Jurjan Aman, Coert Margadant
Integrin-Dependent Cell-Matrix Adhesion in Endothelial Health and Disease. Circulation research 132 (3) (2023)
Jurjan Aman, Coert Margadant
Integrin-Dependent Cell-Matrix Adhesion in Endothelial Health and Disease. Circulation research 132 (3) (2023)
Rachel Walters, Eleni Vasilaki, Jurjan Aman, Chien-Nien Chen, Yukyee Wu, Olin D Liang, Ali Ashek, Olivier Dubois, Lin Zhao, Farah Sabrin, Inês Cebola, Jorge Ferrer, Nicholas W Morrell, James R Klinger, Martin R Wilkins, Lan Zhao, Christopher J Rhodes
SOX17 Enhancer Variants Disrupt Transcription Factor Binding And Enhancer Inactivity Drives Pulmonary Hypertension. Circulation (2023)
Chiara E Geyer, Hung-Jen Chen, Alexander P Bye, Xue D Manz, Denise Guerra, Tom G Caniels, Tom Pl Bijl, Guillermo R Griffith, Willianne Hoepel, Steven W de Taeye, Jennifer Veth, Alexander Pj Vlaar, null null, Gestur Vidarsson, Harm Jan Bogaard, Jurjan Aman, Jonathan M Gibbins, Marit J VAN Gils, Menno P J de Winther, Jeroen den Dunnen
Identification of new drugs to counteract anti-spike IgG-induced hyperinflammation in severe COVID-19. Life science alliance 6 (11) (2023)
Xue D Manz, Harm Jan Bogaard, Jurjan Aman
Regulation of VWF (Von Willebrand Factor) in Inflammatory Thrombosis. Arteriosclerosis, thrombosis, and vascular biology 42 (11) (2022)
Liza Botros, Manon C A Pronk, Jenny Juschten, John Liddle, Sofia K H Morsing, Jaap Diederik van Buul, Robert H Bates, Pieter R Tuinman, Jan S M van Bezu, Stephan Huveneers, Harm Jan Bogaard, Victor W M van Hinsbergh, Peter L Hordijk, Jurjan Aman
Bosutinib prevents vascular leakage by reducing focal adhesion turnover and reinforcing junctional integrity. Journal of cell science 133 (9) (2020)
Jurjan Aman, G Kees Hovingh
Multilevel omics: A next step on the way to understanding pulmonary arterial hypertension? Thorax 74 (4) (2019)